SEVERE HEMOPHILIA A
Clinical trials for SEVERE HEMOPHILIA A explained in plain language.
Never miss a new study
Get alerted when new SEVERE HEMOPHILIA A trials appear
Sign up with your email to follow new studies for SEVERE HEMOPHILIA A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo approach may help hemophilia patients undergo major surgery safely
Disease control Recruiting nowThis study looks at whether a medicine called Nuwiq (recombinant factor VIII) can safely prevent bleeding during major surgery in people with severe hemophilia A who are already on a regular treatment called emicizumab. About 28 male patients aged 12 and older will take part. The…
Matched conditions: SEVERE HEMOPHILIA A
Phase: PHASE4 • Sponsor: Octapharma • Aim: Disease control
Last updated May 26, 2026 04:51 UTC
-
New shot for hemophilia a: could marstacimab be a Game-Changer?
Disease control Recruiting nowThis study tests a new medicine called marstacimab for people with severe hemophilia A who want to switch from their current treatment (emicizumab). Hemophilia A is a rare bleeding disorder where blood doesn't clot properly. The study will check if marstacimab is safe and how it …
Matched conditions: SEVERE HEMOPHILIA A
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 22, 2026 13:51 UTC